Fulminant hepatitis
Springer Seminars in Immunopathology · 1990
DOI: 10.1007/bf00192680 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Springer Seminars in Immunopathology, 1990. Verfasst von S Sinclair und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto, Canada. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
ConclusionIn conclusion, evidence exists that cellular and humoral immune-mediated processes result in hepatic necrosis in FH. Activation of the immune coagulation system appears to be an integral part of the inflammatory process resulting in fibrin thrombi which have been demonstrated in the liver, kidneys and lungs of patients with FH. A beneficial role of PG in the treatment of FH has been demonstrated, but controlled trials are required to firmly establish the efficacy of these agents. At present liver transplantation remains the treatment of choice in selected patients with FH. Further studies of the role of the immune system in the pathogenesis of this disease are required to devise more effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Toronto, Canada.
Förderung
- Wellcome Trust
Zitieren
APA
Sinclair, S., Wakefield, A., & Levy, G. (1990). Fulminant hepatitis. Springer Seminars in Immunopathology. https://doi.org/10.1007/bf00192680
Vancouver
Sinclair S, Wakefield A, Levy G. Fulminant hepatitis. Springer Seminars in Immunopathology. 1990. doi:10.1007/bf00192680
BibTeX
@article{Sinclair1990,
author = {Sinclair, S and Wakefield, A and Levy, G},
title = {Fulminant hepatitis},
journal = {Springer Seminars in Immunopathology},
year = {1990},
doi = {10.1007/bf00192680}
}
EUVIMED